Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: Queensland Institute of Medical Research (QIMR) Berghofer and Royal Brisbane and Women’s Hospital
Location: Royal Brisbane Women’s Hospital, Bowen Bridge Rd & Butterfield St, Herston QLD
Lead Doctor: Dr Christine Guo
Ethics Committee: This study has been reviewed and approved by Royal Brisbane Women’s Hospital Human Research Ethics Committee

Researcher interview:

Background

It can be very difficult to diagnose Alzheimer’s disease (and other dementia diseases) in its early stages. Delayed diagnosis can bring frustration and confusion to the patients and families, and prevent proper treatment early on.

In this study, a simple, non-invasive nasal test is being developed to potentially help with early detection of Alzheimer’s disease.

This study seeks men and women who have been diagnosed with Alzheimer’s disease and are able to provide informed consent. Participants are required to attend 1 study visit at the research site and will be compensated $50 for participating in this study.

Benefits of Participation

• You will be helping to advance Alzheimer’s disease medical research.
• You will learn more about your disease.
• You will be compensated $50 per visit for participating in this study.

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

• Men and women aged 35 – 85 years old who have been diagnosed with Alzheimer’s disease.
• Able to provide informed consent.
• Able to attend 1 study visit at the research site.